About / News
On mobile devices, tap the image to read the article.
March 23, 2022
At Biogenity, we are happy to announce that the Innovation Fund Denmark has agreed to invest in Biogenity's Innobooster-project: "Signal Pathway Intelligent Characterization (SWITCH)." SWITCH will be a series of algorithms to track molecular signals in expression-based omics data. One of the biggest problems in omics studies is the complexity, especially in multi-omics studies when discovering new diagnostics, prognostics, and therapeutics targets.
June 01, 2021
At Biogenity, we are very proud to be able to facilitate your proteomics project using Mass Spectrometry. Since we have not posted on our proteomics workflow, we thought it would be obvious to present the whole customer journey, highlighting how to support your next project from sample to biology.